Eris Lifesciences Q1 Results
- BSE: 540596
- NSE: ERIS
- ISIN: INE406M01024
- Sector: Biotechnology & Drugs
BSE
1,355.00
0.35 (0.03%)
0.35 (0.03%)Volume519.00
Updated: Fri 11 Sep, 2026 | 15:28:24
NSE
1,355.50
-1.10 (-0.08%)
-1.10 (-0.08%)Volume24.97 K
Updated: Fri 11 Sep, 2026 | 15:29:56
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹873.25 Cr.(12.97%)
- Operating Profit₹224.15 Cr.(8.71%)
- Profit After Tax₹142.39 Cr.(20.68%)
- Operating Margin25.67%(-3.77%)
Note: Comparison is on YoY basis
Quarterly - Eris Lifesciences Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 649.10 | 552.55 | 17.47% | 545.67 | 14.52% |
| Depreciation/ Amortization | 72.07 | 69.57 | 3.59% | 75.94 | 2.21% |
| Operating Income | 224.15 | 204.01 | 9.87% | 174.05 | 8.71% |
| Net Income | 142.39 | 281.62 | -49.44% | 83.18 | 20.68% |
| Other Operating Expenses Total | 184.36 | 160.88 | 14.59% | 156.52 | 10.25% |
| Net Income Before Taxes | 179.49 | 159.42 | 12.59% | 115.32 | 11.42% |
| Total Revenue | 873.25 | 756.56 | 15.42% | 719.72 | 12.97% |
| Selling/ General/ Admin Expenses Total | 153.42 | 136.85 | 12.11% | 132.62 | 6.22% |
| Diluted Normalized EPS | 10.26 | 20.37 | -49.63% | 6.10 | 18.75% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.